Benzinga Rankings give you vital metrics on any stock – anytime.
Explore Inhibrx Biosciences stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for INBX.
You can purchase shares of Inhibrx Biosciences (NASDAQ:INBX) through any online brokerage.
Other companies in Inhibrx Biosciences’s space includes: Innate Pharma (NASDAQ:IPHA), Voyager Therapeutics (NASDAQ:VYGR), Tango Therapeutics (NASDAQ:TNGX), Tevogen Bio Holdings (NASDAQ:TVGN) and Sangamo Therapeutics (NASDAQ:SGMO).
Inhibrx Biosciences has a consensus price target of $47.00.
The stock price for Inhibrx Biosciences (NASDAQ: INBX) is $11.88 last updated April 14, 2025 at 4:00 PM EDT.
There are no upcoming dividends for Inhibrx Biosciences.
Inhibrx Biosciences’s Q1 earnings are confirmed for Thursday, May 8, 2025.
There is no upcoming split for Inhibrx Biosciences.
Inhibrx Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.